000			02061 a2200505 4500
005			20250513161028.0
264		0	_c19990128
008			199901s 0 0 eng d
022			_a0013-7227
024	7		_a10.1210/endo.140.1.6414 _2doi
040			_aNLM _beng _cNLM
100	1		_aLamm, M L
245	0	0	_aEpidermal growth factor-induced heterologous desensitization of the luteinizing hormone/choriogonadotropin receptor in a cell-free membrane preparation is associated with the tyrosine phosphorylation of the epidermal growth factor receptor. _h[electronic resource]
260			_bEndocrinology _cJan 1999
300			_a29-36 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives
650	0	4	_aAdenosine Diphosphate Ribose _xmetabolism
650	0	4	_aAdenylate Cyclase Toxin
650	0	4	_aAdenylyl Cyclases _xmetabolism
650	0	4	_aAnimals
650	0	4	_aCell-Free System
650	0	4	_aChorionic Gonadotropin _xpharmacology
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEpidermal Growth Factor _xpharmacology
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aFemale
650	0	4	_aGTP-Binding Protein alpha Subunits, Gi-Go _xmetabolism
650	0	4	_aGenistein _xpharmacology
650	0	4	_aMembrane Proteins _xdrug effects
650	0	4	_aOvary _xdrug effects
650	0	4	_aPertussis Toxin
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinase Inhibitors
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aRats
650	0	4	_aReceptors, LH _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTyrosine _xmetabolism
650	0	4	_aVirulence Factors, Bordetella _xpharmacology
700	1		_aRajagopalan-Gupta, R M
700	1		_aHunzicker-Dunn, M
773	0		_tEndocrinology _gvol. 140 _gno. 1 _gp. 29-36
856	4	0	_uhttps://doi.org/10.1210/endo.140.1.6414 _zAvailable from publisher's website
999			_c9848584 _d9848584